Skip to content
Research Article Open access CC BY 3.0

Etiology and Drug Resistance Pattern of Ventilator Associated Pneumonia in an Iranian 1000- Bed Tertiary Care Hospital

H. Bahrami, M. Rahbar, N. Rahimifard, H. Haji Mehdipour, H. Rastegar, H. R. Ahmadi Ashtiani, F. Bagheri, M. Saremi

Microbiology Research Journal International · pp. 1211–1218 · Published 7 Jul 2014

10.9734/BMRJ/2014/7543

Abstract

Aim: The aim of this study was to determine etiology and drug resistance pattern of most frequency isolates of microorganisms responsible for VAP in an Iranian 1000-bed tertiary care hospital in Tehran Iran. Place and Duration: This study was conducted in microbiology laboratory of Milad Hospital in Tehran, Iran from November 2010 to December 2011. Methodology: Ventilator Associated Pneumonia (VAP) was defined as any lower respiratory tract infection that developed 48 hours after mechanical ventilation. Tracheal aspirate specimens were collected and processed according standard microbiological procedures. Bacterial identification and susceptibility testing were performed using disk diffusion standard procedures as recommended by CLSI. Results: One hundred and one patients developed at least one episode of nosocomial pneumonia were subject of our study. Of 101 patients 61 patients were male and 40 female patients. The mean time for hospitalization in ICUs and ventilation duration were 16 and 9, 5 days respectively. Old age, History of previous use of antibiotics and duration of ventilation times were the most important risk factors for VAP. In total 126 microorganisms were isolated from VAP cases. Acinetobacer baumannii with 46 (36.5%) isolates was the predominant organism followed by Staphylococcus aureus with 31 (24. 60% and Pseudomonas aeruginosa with 19 (15%) isolates. Other isolated organisms included Klebsiella pneumoniae and E. coli. The majority isolated organism included Acinetobacter baumannii and Pseudomonas aeruginosa were resistant to many antibiotics including the third generation of cephalosporins and nearly 50% isolates were resistant to amikacin. Colistin was the most effective antibiotic against multidurug resistant (MDR) isolates. We found a high rate of methicillin resistant Staphylococcus aureus (93.54%). All isolates of S. aureus were susceptible to vancomycin. Conclusion: Our study revealed that A. baumannii, S. aureus and P. aeruginosa were the major etiological agents of VAP in our hospital. The majority isolates were resistant to routinely used antibiotics including the third generation of cephalosporins. We also observed a high rate of MRSA among our isolates.

Ventilator associated pneumonia drug resistance

References (21)

  1. 1 Diagnosis of Ventilator-associated Pneumonia by Bacteriologic Analysis of Bronchoscopic and Nonbronchoscopic “Blind” Bronchoalveolar Lavage Fluid [DOI]
  2. 2 Ventilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria [DOI]
  3. 3 Diagnosis of ventilator-associated pneumonia: a systematic review of the literature [DOI]
  4. 4 Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors [DOI]
  5. 5 Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality [DOI]
  6. 6 Diagnosis and Treatment of Ventilator-Associated Pneumonia [DOI]
  7. 7 Epidemiology of Ventilator-Associated Pneumonia [DOI]
  8. 8 Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia [DOI]
  9. 9 Microbial investigation in ventilator-associated pneumonia [DOI]
  10. 10 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia [DOI]
  11. 11 Therapeutic options forAcinetobacter baumanniiinfections: an update [DOI]
  12. 12 A Prospective Assessment of Diagnostic Efficacy of Blind Protective Bronchial Brushings Compared to Bronchoscope-Assisted Lavage, Bronchoscope-Directed Brushings, and Blind Endotracheal Aspirates in Ventilator-Associated Pneumonia [DOI]
  13. 13 Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome.
  14. 14 Ventilator-associated pneumonia in Iranian intensive care units [DOI]
  15. 15 Ventilator associated pneumonia in a medical intensive care unit: Microbial aetiology, susceptibility patterns of isolated microorganisms and outcome [DOI]
  16. 16 Point-Counterpoint: Quantitative Cultures of Bronchoscopically Obtained Specimens Should Be Performed for Optimal Management of Ventilator-Associated Pneumonia [DOI]
  17. 17 Role of quantitative endotracheal aspirate and cultures as a surveillance and diagnostic tool for ventilator associated pneumonia: A pilot study [DOI]
  18. 18 Ventilator-associated pneumonia: Problems with diagnosis and therapy [DOI]
  19. 19 Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: A comparison of the EUVAP and LATINVAP study cohorts [DOI]
  20. 20 A survey on microorganisms and their sensitivity by E-test in ventilator-associated pneumonia at Toxicological-Intensive Care Unit of Loghman-Hakim Hospital.
  21. 21 Detection and Quantitation of the Etiologic Agents of Ventilator-Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran [DOI]

Cited by 2

BACTERIOLOGICAL STUDY OF VENTILATOR-ASSOCIATED PNEUMONIA AND ANTIBIOTIC SUSCEPTIBILITY OF ISOLATES

VIJAYA KUMAR KANIPAKAM, HIMABINDU THOTI, YAMINI SHARABU · International Journal of Current Pharmaceutical Research · 2024

Article metrics

Real usage data collected on this platform.

62

Page views

0

PDF downloads

33

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.